Posts with tag IP

Sort by Latest
The Pharmaceutical Intellectual Property and Competition Law Review
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide. Our team of authors, Sally Shorthose, Peter Willis, Chris de...
September 16, 2022
1 min read
First medicinal cannabis drug listed on the Australian...
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product...
May 6, 2021
1 min read
Illumina v MGI: Patents Court gives guidance on the...
In Illumina v Latvia MGI Tech (MGI) [2021]...
March 26, 2021
9 min read
Introduction of the Narcotic Drugs Amendment (Medicinal...
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal...
March 2, 2021
1 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publication and prior use.
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss...
November 19, 2019
5 min read